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Hantaviruses are members of the Bunyaviridae family carried by small mammals and
causing human hemorrhagic fevers worldwide. In Western Africa, where a variety of
hemorrhagic fever viruses occurs, indigenous hantaviruses have been molecularly found
in animal reservoirs such as rodents, shrews, and bats since 2006. To investigate
the human contact to hantaviruses carried by these hosts and to assess the public
health relevance of hantaviruses for humans living in the tropical rainforest regions of
Western and Central Africa, we performed a cross-sectional seroprevalence study in the
region of Taï National Park in Côte d’Ivoire and the Bandundu region near the Salonga
National Park in the Democratic Republic (DR) of Congo. Serum samples were initially
screened with enzyme-linked immunosorbent assays using nucleoproteins of several
hantaviruses as diagnostic antigens. Positive results were confirmed by Western blotting
and immunofluorescence testing. Seroprevalence rates of 3.9% (27/687) and 2.4%
(7/295), respectively, were found in the investigated regions in Côte d’Ivoire and the DR
Congo. In Côte d’Ivoire, this value was significantly higher than the seroprevalence rates
previously reported from the neighboring country Guinea as well as from South Africa.
Our study indicates an exposure of humans to hantaviruses in West and Central African
tropical rainforest areas. In order to pinpoint the possible existence and frequency
of clinical disease caused by hantaviruses in this region of the world, systematic
investigations of patients with fever and renal or respiratory symptoms are required.
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Introduction
Hantavirus infections are responsible for human disease worldwide with up to 200,000
cases estimated per year. As the only bunyaviruses being carried by small mammals, these
zoonotic agents can cause Hemorrhagic Fever with Renal Syndrome (HFRS) or Hantavirus
Cardiopulmonary Syndrome (HCPS) with case fatality rates of up to 50% (Krüger et al., 2011,
2015).
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Sangassou virus as the ﬁrst autochthonous African hantavirus
was found in Guinea, West Africa, in 2006. First serological
studies of patients with fever from the area indicated human
hantavirus infections implying underestimation of hantavirus
public health impact on the African continent (Klempa et al.,
2006, 2010, 2012). During the recent years a high number of novel
hantaviruses from non-conventional hosts, as shrews, moles, and
bats, have been molecularly detected, many of them in Africa (for
a review, see Witkowski et al., 2014). The mere existence of these
vastly uncharacterized viruses induces speculations about their
emergence in further hosts and geographic areas. Particularly in
Africa, where many diseases remain neglected or underreported
due to bad health care conditions, and other hemorrhagic fever
viruses like Lassa or Ebola occur, nearly nothing is known about
the epidemiology and case deﬁnition of hantavirus disease in
humans. The typical clinical symptoms known from hantavirus-
infected patients in the Old and New World include high
fever, hemorrhages, thrombocytopenia, abdominal pain, ﬂu-like
symptoms, and ﬁnally organ failure – symptoms known to be
also caused by many other hemorrhagic fever viruses including
arena-, ﬁlo-, and ﬂaviviruses (Kortepeter et al., 2011; Heinz and
Stiasny, 2012; McLay et al., 2014). Recent outbreaks of zoonotic
diseases, like MERS coronavirus on the Arabian Peninsula (de
Groot et al., 2013) or Ebola virus in West Africa (Baize et al.,
2014), demonstrate a high necessity for intensive studies of highly
pathogenic zoonotic viruses in order to be prepared for their
emergence and major outbreaks.
Here we investigated the presence of hantavirus antibodies in
humans living in the Taï National Park in Côte d’Ivoire as part
of the West African Guinean Forest Block and of the Salonga
National Park in the Democratic Republic (DR) of Congo as
part of the Central African Congo Basin – two regions where
the richest and oldest tropical evergreen rainforest biomes on
Earth exist (Jones, 1994), potentially facilitating close contact and
high exposure of the human population to putative hantavirus
hosts. So-called bush meat, which includes small mammals such
as bats and rodents, is consumed regularly by inhabitants of the
villages in scope. It seems obvious that living within or close to
a biodiversity hotspot, like a tropical forest, leads to high risk
of infection by a variety of infectious agents (Wolfe et al., 2007;
Keesing et al., 2010). While indigenous hantaviruses have already
been found in animal samples from Côte d’Ivoire [Azagny virus
(Kang et al., 2011), Mouyassué virus (Sumibcay et al., 2012)],
DR Congo thus far remains a country without proven hantavirus
occurrence. Nevertheless, bat species shown to carry hantaviruses
elsewhere (Sumibcay et al., 2012; Weiss et al., 2012) naturally
occur in the region.
Materials and Methods
Study Sites and Populations
To screen for seropositive individuals, serum samples were
collected from 16 villages in Taï National Park of Côte d’Ivoire
in 2007 and ﬁve villages in Salonga National Park of DR Congo in
2011 (Figure 1). The investigation was approved by the National
Ethics Commissions of both countries and all participants gave
their approval prior to the sampling. The sera were frozen directly
in the ﬁeld in liquid nitrogen. Altogether 982 samples were
analyzed – for sample composition according to location, see
Table 1. Participants were also asked for professional status to
estimate possible virus exposure and for recent health problems.
Serological Test Algorithm
The collected sera were analyzed following a serodiagnostic
algorithm as described previously (Klempa et al., 2010;
FIGURE 1 | Map of Western/Central Africa showing location of study sites illustrated by circles. The shaded areas mark tropical rain forest biome. CI, Côte
d’Ivoire; DRC, Democratic Republic of Congo.
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TABLE 1 | Sample composition and proof of antibody-positive sera
according to sampling location.
Village Country Seropositives/no. tested
Daobly CI 0/34
Djereoula CI 0/31
Djidoubaye CI 1/38 (2.6%)
Gahably CI 0/54
Goulegui Beoue CI 1/54 (1.9%)
Keibly CI 7/88 (8.0%)
Ponan CI 0/18
Portgentil CI 1/47 (2.1%)
Sakre CI 6/73 (8.2%)
Sioblooula CI 3/34 (8.8%)
Taï CI 0/26
Tieleoula CI 2/36 (5.6%)
Tienkoula CI 2/39 (5.5%)
Zagne CI 0/12
Zaipobly CI 3/35 (8.6%)
Ziriglo CI 1/68 (1.5%)
Total CI 27/687 (3.9%)
Bekombo DRC 0/3
Ipope DRC 1/57 (1.8%)
Iyoko DRC 0/1
Lompole DRC 4/134 (3.0%)
Nganda DRC 2/100 (2.0%)
Total DRC 7/295 (2.4%)
CI, Côte d’Ivoire; DRC, Democratic Republic of Congo.
Witkowski et al., 2014). Shortly, a screening enzyme-
linked immunosorbent assay (ELISA) was performed
using recombinant nucleocapsid antigens from prototypical
hantaviruses including Dobrava-Belgrade virus, Puumala virus
(Meisel et al., 2006), and the African Sangassou virus with a
serum dilution of 1:200. All positive samples were subsequently
tested in an in-house Western Blot (WB) with Sangassou virus
antigen and by recomLine HantaPlus strip blot (Mikrogen,
Germany) according to manufacturer’s speciﬁcations with a
dilution of 1:100. Finally, an in-house immunoﬂuorescence assay
(IFA) with VERO-E6 cells infected with Hantaan, Dobrava-
Belgrade, Puumala, or Sangassou viruses was performed. The
lowest dilution for IFA was 1:20, followed by titration of
samples with suﬃcient volumes available. Sera positive in all
three test formats were considered as hantavirus seropositive.
Focus reduction neutralization assay (FRNT) against Dobrava-
Belgrade, Puumala, and Sangassou viruses was performed for
selected samples, with enough sample material.
Molecular Testing
Samples with high absorbance values in ELISA were also tested
for hantavirus IgM antibodies and, in case of a positive result,
RNA was extracted and screened by pan-hantavirus RT-PCR
(Klempa et al., 2006) to target possible current infections which
exhibit RNAemia.
Statistical Analyses
The database with serodiagnostic results was established
in Excel R© for Windows, before being transferred to Stata
(Stata/SE12.0 for Windows, Stata Corp, College Station, TX,
USA). Seroprevalences were calculated including 95% conﬁdence
intervals (CI). The eﬀect of country, sex, age, village, and
occupation on the serological status was initially investigated
with logistic regression models with serological status as binary
dependent variable and the other factors as independent
variables.
Results
Samples and Demographic Data
A total of 982 blood samples were analyzed in the study,
687 and 295 samples were collected in Côte d’Ivoire and DR
Congo, respectively. The average number of samples per village
was 49 (range 1–134). The mean age of the participants was
35 years (range 3–95, n = 932). 53% of the participants were
females (reported gender, n = 953). Occupation data were
available for 92% (n = 900) of the samples. Most people were
occupied with agriculture (40%, n = 356) or house work (28%,
n = 255), 15% (n = 134) were pupils and the rest reported the
following occupations: teacher/student, sales/business person,
cook/restaurant worker, tailor, driver/mechanic, ﬁsherman,
builder, hunter/meat seller, and health worker. For sample
composition according to profession, age, and gender, see
Table 2.
Serology and Molecular Testing
The conﬁrmed seroprevalence was 3.9% (27/687; 95% CI 2.6–
5.7%) and 2.4% (7/297; 95% CI 1.0–4.8%) for the groups
from Côte d’Ivoire and DR Congo, respectively. There was
no statistical signiﬁcant diﬀerence between the prevalences in
the two countries (p > 0.05). The primary screening ELISA
detected 229/982 seropositive samples against Sangassou virus
antigen and only 28/982 against Puumala virus antigen. Out of
all samples found to be positive in the screening ELISAs, 34
sera were conﬁrmed to be seropositive by all levels of the test
algorithm. Thirty out of the 34 seropositive samples were found
to be reactive (12 of them even exclusively) against Sangassou
virus antigen in the screening ELISA. For detailed results, see
Supplementary Table S1. For 13/34 of the positive sera, where
FRNT was performed, none of the used viruses was neutralized
eﬀectively (data not shown).
Considering all samples collected in the study, seropositive
individuals were detected in 10/16 villages in Côte d’Ivoire
(Djidoubay, Goulegui, Keibly, Portgenti, Sakre, Sioblooula,
Tieleoula, Tienkoula, Zaipobly, and Ziriglo) and in 3/5 villages
in DR Congo (Ipope, Lompole, and Nganda). The prevalence
per village ranged from 0 to 8.8% (see Table 1); there was no
statistical diﬀerence in prevalence between the villages (p> 0.05).
Seropositivity was detected in 19 females and 15 males, in
individuals that were between 3 and 81 years old, and in
people with the following occupation: agriculture, sales/business
persons, pupils, tailors, ﬁshermen, and house workers. There was
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TABLE 2 | Seropositive participants from both study sites according to
profession, age, and gender in both countries.
Analysis by Seropositives/no. tested
Profession
Agriculture 14/356 (3.9%)
House work 9/255 (3.5%)
Pupils 3/134 (2.2%)
Teacher/student 0/27
Sales/business 1/24 (4.2%)
Cook/restaurant 0/19
Tailor 1/17 (5.9%)
Driver/mechanic 0/16
Fisher 1/16 (6.25%)
Various 0/15
Builder 0/9
Hunter/butcher 0/7
Healthcare 0/5
Total 29/900
Age
1–10 1/38 (2.6%)
11–20 7/207 (3.4%)
21–40 14/327 (4.3%)
41–60 5/226 (2.2%)
>60 5/89 (5.6%)
Total 32/932
Gender
Female 19/503 (3.8%)
Male 15/450 (3.3%)
Total 34/953
Profession and age were known for 900 and 932 participants, respectively.
no statistically signiﬁcant eﬀect of gender, age, or occupation
on serology status (p-value for all factors >0.05). The statistical
model explained 8.4% of the variation in the serological status.
There was no statistically signiﬁcant diﬀerence between the
prevalence in Côte d’Ivoire and DR Congo in any village and for
all villages together (p> 0.05).
In comparison to previous studies, the prevalence was
signiﬁcantly higher (p = 0.002) in Côte d’Ivoire than reported for
Guinea [1.2% (Klempa et al., 2010); 8/649; 95% CI 0.5–2.4%] and
South Africa [1.0% (Witkowski et al., 2014); 14/1442; 95% CI 0.5–
1.5%]. RT-PCR testing of 13 individuals with high IgM values did
not reveal any detectable viremia within the study group.
Health Problems within Study Population
Self-reported symptoms among the probands included problems
common in African villages: 36% of the participants reported
at least one type of recent health problem. Most common were
malaria (n = 127), cough (n = 55), back pain (n = 47),
and abdominal pain (n = 37). Four people reported fever.
Of the hanta seropositive people four reported malaria, six
reported cough, ﬁve reported back pain, two reported abdominal
pain, and nine reported other symptoms. No hanta positive
person reported fever only. Self-reported “malaria” is likely
meaning symptoms that include fever. The self-reported medical
information was not included into the statistical model due to the
large number of diﬀerent symptoms.
Discussion
Our work shows that people in the two studied African regions
carry antibodies against hantavirus, strongly suggesting their
previous exposure to this pathogen. For two countries so far
not investigated in this matter, seroprevalence rates of 3.9%
in Côte d’Ivoire and 2.4% in DR Congo were ascertained. In
recent studies performed in Guinea and in South Africa with
the same antigens and methodology, seroprevalence rates of 1.2
and 1.0%, respectively, were found in the average populations
(Klempa et al., 2010; Witkowski et al., 2014), while elevated
hantavirus seroprevalence (4.4%) could be found among Guinean
patients with uncharacterized fever (Klempa et al., 2010, 2013).
Our study demonstrates a signiﬁcantly higher seroprevalence
of hantavirus antibodies within the major tropical rainforest
region of Côte d’Ivoire (but not DR Congo) in comparison to
our ﬁndings from Guinea or South Africa. This indicates that
some populations living in tropical forest regions with their rich
biodiversity and high potential for close contact to, e.g., wildlife
hosts encounter relatively higher exposure to hantaviruses. While
there is molecular evidence for the occurrence of bat- and
shrew-associated hantaviruses in Côte d’Ivoire (Kang et al., 2011;
Sumibcay et al., 2012), the association of these particular viruses
with the human infections remains, however, to be shown.
About 97% of people above 16 years participating in the study
reported consumption of rodents and other small mammals.
Professional exposure seemed not to play a statistically signiﬁcant
role within our study group, however, occupations in agriculture
and meat preparation, usually having a higher risk for hantavirus
infections (Mertens et al., 2011), made up more than 70% of
the probands, not including pupils. Many participants usually
helped out in agriculture during harvest season, even if they work
somewhere else, or they change occupation frequently. All these
inﬂuencing variables might contribute to the postulated high
exposure.
Among the study group, many people reported a large variety
of recent health problems that are common in African villages,
mainly malaria (probably meaning fever and headache), cough,
back pain, and abdominal pain. On the other hand no serious
health problems typical for hantavirus disease with severe course,
like hemorrhages or organ failure (Krüger et al., 2011), were
mentioned. Hantavirus-seropositive people did not report more
health problems than the rest of the study group. In future studies
a speciﬁc survey of patients with fever and hemorrhages should
be a focal point for an investigation of hantavirus disease within
the tropical forest biome.
Assuming a seroprevalence of 3.9 % in the entire population
of Côte d’Ivoire and considering the data from Germany
[seroprevalence 1.7% (Zöller et al., 1995), incidence 3.40 (Krüger
et al., 2013)] and Finland [seroprevalence 5%, incidence 43.20
(Vaheri et al., 2013)], one could expect the occurrence of up
to 7,000 clinical cases/year for an estimated population of
∼20 millions.
Frontiers in Microbiology | www.frontiersin.org 4 May 2015 | Volume 6 | Article 518
Witkowski et al. Hantavirus infections in African tropical forest
The immunoassays used in the study exploit the
immunodominance of hantavirus nucleocapsid protein (Meisel
et al., 2006) within the infected organism. The use of antigens
from African Sangassou virus, but also from Puumala and
Dobrava-Belgrade viruses, within our screening increased (due
to cross reactivity) the chance of detecting also hantavirus
antibodies directed against still uncharacterized, indigenous
viruses (Araki et al., 2001; Kucinskaite-Kodze et al., 2010). The
cascade of conﬁrmatory tests was used to exclude false positive
results even though it might have decreased the sensitivity.
The fact that the primary screening ELISA detected 229/982
samples as positive against Sangassou virus but only 28/982
samples positive against Puumala virus supports the hypothesis
of a Sangassou-like virus being the agent responsible for the
infections. Finally, the relatively low number of samples positive
in all conﬁrmatory assays makes calculations statistically diﬃcult.
In future studies the usage of antigens from additional indigenous
rodent-, insectivore-, and bat-borne viruses should be forced
which is hampered by restricted sequence information for novel
African viruses and the complete lack of cell culture isolates of
viruses except for Sangassou virus.
In all 13 IgG-positive samples found to be also IgM-positive,
no viral RNA was found by RT-PCR techniques. This is not
surprising as hantavirus nucleic acid can be usually detected only
up to 30 days after infection under good sampling and laboratory
conditions (Ettinger et al., 2012; Korva et al., 2013), while IgM can
last for up to 2 years (Meisel et al., 2006; Hofmann et al., 2014).
The high proportion of samples positive in Sangassou
virus-speciﬁc ELISA allows to assume that a close relative
could be present in the investigated regions. The fact that
six indigenous hantaviruses have been molecularly detected
in recent years in Western Africa, together with our results
presented here, consolidate this region as a putative hantavirus
hotspot. The existence of very diverse hantaviruses hosted by
diﬀerent animal species within the area could lead to the
emergence of new variants with high public health impact. We
are convinced that more alertness should be paid to possible
human hantavirus infections, particularly in the western part of
Africa.
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